Publication: Population access to new vaccines in European countries
Population access to new vaccines in European countries
Date
Date
Date
Citations
Blank, P. R., Schwenkglenks, M., Sardos, C. S., Patris, J., & Szucs, T. D. (2013). Population access to new vaccines in European countries. Vaccine, 31(27), 2862–2867. https://doi.org/10.1016/j.vaccine.2013.04.039
Abstract
Abstract
Abstract
Time from registration to population access to new vaccines can take considerable time in European countries. Reasons might be found in the regulatory framework, decision-making processes or the assessment of vaccines by evaluating bodies. The aim of this study was to determine whether some decision-making processes can explain between-country differences in the time to population access to new vaccination programs. Information gathered from a survey among European National Vaccine Industry Groups was combined with information from of
Metrics
Views
Additional indexing
Creators (Authors)
- Blank, Patricia R
- Schwenkglenks, Matthias
- Sardos, Christelle Saint
- Patris, Julien
- Szucs, Thomas D
Volume
Volume
Volume
Number
Number
Number
Page Range
Page Range
Page Range
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Views
Citations
Blank, P. R., Schwenkglenks, M., Sardos, C. S., Patris, J., & Szucs, T. D. (2013). Population access to new vaccines in European countries. Vaccine, 31(27), 2862–2867. https://doi.org/10.1016/j.vaccine.2013.04.039